seganserin has been researched along with Hepatic Encephalopathy in 1 studies
*Hepatic Encephalopathy: A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferenci, P; Herneth, AM; Püspök, A; Singer, E; Steindl, P; Yurdaydin, C | 1 |
1 other study(ies) available for seganserin and Hepatic Encephalopathy
| Article | Year |
|---|---|
Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonists.
Topics: Animals; Dose-Response Relationship, Drug; Hepatic Encephalopathy; Male; Methysergide; Motor Activity; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Thioacetamide | 1996 |